[Primary and secondary syphilis: epidemiology, diagnosis and treatment].
Janier
M
M
Centre clinique et biologique des maladies sexuellement transmissibles, hôpital Saint-Louis, Paris.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002601:Chancre / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications; D006679:HIV Seropositivity / Q000150:complications; D006801:Humans; D015994:Incidence; D007273:Injections, Intramuscular; D008297:Male; D009494:Neurosyphilis / Q000175:diagnosis; D010400:Penicillin G / Q000008:administration & dosage; D010401:Penicillin G Benzathine / Q000008:administration & dosage; D010406:Penicillins / Q000008:administration & dosage; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012307:Risk Factors; D013588:Syphilis Serodiagnosis; D013591:Syphilis, Cutaneous / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D013592:Syphilis, Latent / Q000175:diagnosis; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013752:Tetracycline; D004318:Doxycycline; D010400:Penicillin G; D010401:Penicillin G Benzathine